Amy Werremeyer, PharmD, BCPP

118H Sudro Hall


Pharmacy Practice Residency 2005-2006
Veteran's Affairs Medical Center
Fargo, North Dakota

Doctor of Pharmacy, 2005
North Dakota State University

Bachelor of Science, Pharmacy, 2003 
North Dakota State University


Chair, Department of Pharmacy Practice
Professor, Department of Pharmacy Practice


School of Pharmacy Curriculum Committee
Pharmacy Continuing Professional Education Committee
NDSU Technology and Instructional Services Committee (Chair)
Sanford Health Pharmacy Residency Advisory Committee

Areas of Expertise 

  • Upstream prevention of opioid related harms
  • Stigma related to substance use disorders and mental illness
  • Patient education and medication experiences with psychotropic medications
  • Photovoice
  • Psychopharmacology—especially antidepressants

Professional Memberships

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
College of Neurologic and Psychiatric Pharmacists
North Dakota Society of Health Systems Pharmacists


Pharmacy 536/636: Pharmacotherapy: Neurology/Psychiatry
Pharmacy 581-583: Clinical Clerkship: Psychiatry
University 189: Skills for Academic Success

Pharmacist Licensure

North Dakota

Recent Publications

Strand M, Eukel H, Frenzel O, Skoy E, Steig J, Werremeyer A. Program Evaluation of the Opioid and Naloxone Education (ONE Rx) Program Using the RE-AIM Model. Research in Social and Administrative Pharmacy. 2020;16:1248-1254.  

Werremeyer A, Skoy E, Burns W, Bach-Gorman A. Photovoice as an Intervention for College Students Living with Mental Illness, a Pilot Study. Mental Health Clinician. 2020; 10(4): 237–243.   

Skoy E, Eukel H, Werremeyer A, Frenzel O, Strand M, Steig J. Implementation of a Statewide Program within Community Pharmacies to Prevent Opioid Misuse and Accidental Overdose. Journal of the American Pharmacists Association. 2020;60(1):117-121.  

Werremeyer A, Skoy E. Using Photovoice to Study Patient Experience with Psychotropic Medications. SAGE Research Methods Cases. 2020.   

Skoy E, Werremeyer A. Comparison of Photovoice to Traditional Reflection to Identify Student Learning During an International Health Experience. American Journal of Pharmaceutical Education. 2020;84(4):7599. DOI:  

Werremeyer A, Skoy E, Marvanova M, Jarajapu Y, Brynjulson R, Wilhelm R, Eukel H. A PharmD Program Curricular Approach to Addressing the Opioid Crisis. Currents in Pharmacy Teaching and Learning. 2019;11(6):592-602.  

Skoy E, Werremeyer A. The Opioid Crisis- Educating the Next Generation of Pharmacists. Currents in Pharmacy Teaching and Learning. 2019;11(5):431-432.   

Skoy E, Eukel H, Frenzel J, Werremeyer A. Preparing Student Pharmacists to Identify Opioid Misuse, Prevent Overdose, and Prescribe Naloxone. Currents in Pharmacy Teaching and Learning. 2019;11(5):522-527.  

Eukel H, Skoy E, Werremeyer A, Burck S, Strand M. Changes in Pharmacists’ Perceptions Following a Training in Opioid Misuse and Accidental Overdose Prevention. Journal of Continuing Education in the Health Professions. 2019 Winter;39(1):7-12. doi: 10.1097/CEH.0000000000000233.  

Skoy E, Werremeyer A. Using Photovoice to Document Living with Mental Illness on a College Campus. Clinical Medicine Insights: Psychiatry. Published online first January 5, 2019.  

Werremeyer A, Orr M. Pharmacist-Led Medication Education Groups on an Inpatient Psychiatric Unit—Impact on Readmissions and Emergency Department Visits. Journal of the American College of Clinical Pharmacists. 2018;2(3):228-235.  

Nelson E, Werremeyer A, Skoy E, Aalgaard Kelly G. Self-Stigma of Antidepressant Users Through Secondary Analysis of PhotoVoice Data. Mental Health Clinician. 2018;8(5):214-221.  

Werremeyer A, Skoy E, Aalgaard Kelly G. Medication Experience of Psychotropic Medications through Photovoice. Qualitative Health Research. Published online March 1, 2017. DOI: 10.1177/10497323176932. 

Werremeyer A, Skoy E, Aalgaard-Kelly G. Photovoice to Characterize Learning during an International Health Experience. Pharmacy. 2016;4(4):39-48. 

Skoy E, Frenzel J, Eukel H, Werremeyer A, McDaniel B. Hearing Voices. American Journal of Pharmaceutical Education. 2016;80(8): Article 142. 

Barnacle M, Strand M, Werremeyer A, Maack B, Petry N. Depression screening in diabetes care to improve outcomes: Are we meeting the challenge? The Diabetes Educator. Published online first August 24, 2016 as doi:10.1177/0145721716662917. 

Werrremeyer A, Aalgaard-Kelly G, Skoy E. Living with My Medication: Using Photovoice to explore patients’ experiences with mental health medication. The Mental Health Clinician. 2016;6(3):142-153. 

Willborn R, Barnacle M, Maack B, Werremeyer A, Strand MA.  Utilization of the 9-Item Patient Health Questionnaire for Depression Assessment in Type-2 Diabetic Primary Care Patients. Journal of Psychosocial Nursing and Mental Health Services. 2016;54(1):56-63. 

Werremeyer A, Strand M, Maack B, Barnacle M, Petry N. Disease Control Among Patients with Diabetes and Severe Depressive Symptoms. Journal of Primary Care and Community Health. 2016;7(2):130-34.  

Goldstone L, Saldana S, Werremeyer A. Guidelines for Pharmacist Provision of Patient Medication Education Groups. American Journal of Health-System Pharmacy. 2015; 72:487-92.  

Willborn R, Werremeyer A, Petry N, Barnacle M, Maack B, and Strand MA. A cross-sectional cohort study comparing health outcomes among type 2 diabetes patients with contrasting depression severity. NTIS #TR-06-2015. Western States Medical Monographs Series, 2015.  

Werremeyer A, Vandenberg A. Headache. In: Murphy J, Wun-Len Lee M, ed. Pharmacotherapy Self-Assessment Program 2015 Book 2. Lenexa, KS: American College of Clinical Pharmacists;2015:73-92.  

Werremeyer A. Surveying the Landscape: Treatment Selection for Depression. In: Recovery in Major Depression: Strategies Beyond the Dopamine Hypothesis. 2015. Available at:

Aalgaard-Kelly G, Werremeyer A, Skoy E. Utilizing Photovoice Methodology to Examine Mental Health Medication Use. Australian Consortium for Social and Political Research Incorporated (ACSPRI) Social Science Methodology Conference Proceedings. 2014.  

Werremeyer A. Retrospective Review of a Case of Serotonin Syndrome after Discontinuation of Risperidone: Was Withdrawal Neuroleptic Malignant Syndrome Missed? (Case Report). Mental Health Clinician (MHC).2013;3(3).

Werremeyer A, Skoy E. A Medical Mission to Guatemala as an Advanced Pharmacy Practice Experience. American Journal of Pharmaceutical Education. 2012; 76(8): Article 156.

Werremeyer A. Patient Education by Pharmacists. The Mental Health Clinician. 2012; 2(10): Article 1.

Werremeyer A. Medication Therapy Management: Don’t leave the medical home without it… The Mental Health Clinician (MHC). August 2011.

Werremeyer A.  “Book Review:100 MTM Tips for the Pharmacist.” The Mental Health Clinician. August 2011.

Kelsch M, Werremeyer A. Public Health Poster Project in a Doctor of Pharmacy Program.  American Journal of Pharmaceutical Education. 2011;75(1):Article 2

Kelsch M, Werremeyer A. Current Events Project in a Pharmacotherapy Course. American Journal of Pharmaceutical Education. 2010; 74 (4):Article 58.

Werremeyer A. Guatemala Medical Mission 2010. NoDak Pharmacy. 2010;23(3):22-3.

Werremeyer A. Ziprasidone and Citalopram Use in Pregnancy and Lactation in a Woman with Psychotic Depression. (Letter). American Journal of Psychiatry. 2009;166(11):1298.

Werremeyer A. Spirituality and Religion in Pharmacy Practice. In Essentials of  Cultural Competence in Pharmacy Practice. Halbur, KV & Halbur, DA, Ed. Washington, DC: American Pharmacists Association; 2008:185-209.

Werremeyer A. Aging and Mental Health Education: Mental Health Clinicians Training Online CEU Course. Mental Health and Aging Project, Department of Child Development and Family Science, North Dakota State University, Fargo, ND. 2007

Werremeyer A, Koo J, Welch J  "A Comparison of Adverse Effects of Simvastatin plus Gemfibrozil and Atorvastatin plus Gemfibrozil" Hospital Pharmacy.  2006

Awards and Certifications

Sudhir Mehta International Travel Award 2012
Faculty Preceptor of the Year 2012
Teacher of the Year 2012
Board of Pharmaceutical Specialties (BPS) Board Certification in Psychiatry Pharmacy 2010
Certified Diabetes Disease State Manager, About the Patient Diabetes Disease Statement Management Program 

Top of page